[128] By contrast, other DAT inhibitors which include bupropion have not been observed to show this outcome.[129] These observations have prompted the hypothesis that methylphenidate may act as a "DAT inverse agonist" or "detrimental allosteric modifier in the DAT" by reversing the course from the dopamine efflux from the DAT at better dosages.[a h